CORRESP 1 filename1.htm

 

Text

Description automatically generated

 

 

Attorneys at Law | 711 Third Ave., New York, NY 10017-4014

T (212) 907-7300 | F (212) 754-0330 | www.golenbock.com

 

Direct Dial No.: (212) 907-7349

Direct Fax No.: (212) 754-0330

Email Address: AHudders @GOLENBOCK.COM

 

October 25, 2024

 

United States Securities and Exchange Commission

Division of Corporation Finance – Office of

Life Sciences

Washington, DC 20549

 

Attention:     Mr. Tyler Howes

Ms. Laura Crotty

Ms. Christine Torney

Ms. Lynn Dicker

 

  Re:

Invizyne Technologies Inc. (“Invizyne”)

File No. 333-276987 

 

Dear Mr. Howes:

 

Pursuant to our conversation this morning, here are five financings where there was a concurrent private placement, three of which were IPOs.

 

BioAge Labs, Inc.

IPO

September 25, 2024

Registration Nos. 281901 and 282334

https://www.sec.gov/Archives/edgar/data/1709941/000119312524226927/d835745d424b4.htm

 

Landbridge Company LLC

IPO

June 27, 2024

Registration Statement No. 333-279893

https://www.sec.gov/Archives/edgar/data/1995807/000119312524172433/d752700d424b4.htm

 

Clearsign Technologies Corp.

Secondary

April 19, 2024

Registration No. 333-265967

https://www.sec.gov/Archives/edgar/data/1434524/000110465924050203/0001104659-24-050203-index.html

 

LegalZoom.com, Inc.

IPO

June 29, 2021

Registration No. 333-256803

https://www.sec.gov/Archives/edgar/data/1286139/000119312521204774/d146270d424b4.htm

 

Safehold Inc.

Secondary

August 7, 2023

Registration No. 333-271113

https://www.sec.gov/Archives/edgar/data/1095651/000110465923089339/0001104659-23-089339-index.html

 

As mentioned in the telephone call, the one individual that is committed to the warrant purchase is a long term investor in MDB Capital transactions. He is an investor in MDB Capital Holdings LLC, so he is currently an indirect investor in Invizyne, through that limited liability company, which is treated as a partnership. This investor is making a substantial investment in the initial public offering of Invizyne. There is a possible second person that would be similarly situated. There are only two such persons that would participate in the private placement.

 

Please contact me for further information.

 

Sincerely,

 

/s/ Andrew D. Hudders  

Andrew D. Hudders